Connect with us

COVID19

Covid-19: The New Coronavirus Disease Now Officially Has A Name

WHO’s technical guidance defines a “person with laboratory confirmation of 2019-nCoV infection, irrespective of clinical signs and symptoms”.

Published

on

GENEVA (Switzerland): There is now have an official name for the disease caused by the new coronavirus, which has killed more than 1000 people so far: Covid-19. The World Health Organization (WHO) made the announcement in a tweet on 11 February. The name is a shortened version of coronavirus disease 2019.

We had to find a name that did not refer to a geographical location, an animal, an individual or group of people, and which is also pronounceable and related to the disease,” the WHO says.

The decision was based on guidelines agreed between WHO, the World Organisation for Animal Health and the Food and Agriculture Organization of the United Nations.


Having a name matters to prevent the use of other names that can be inaccurate or stigmatizing. It also gives us a standard format to use for any future coronavirus outbreaks,” the WHO continued.

The virus itself is called 2019-nCoV, although it is often referred to as the novel coronavirus by the WHO. It has also been called the new coronavirus or 2019 coronavirus, and in the media, it is increasingly just called the coronavirus.

It isn’t yet clear whether someone with mild symptoms could be said to have Covid-19, or whether it refers only to the more severe cases.


However, the WHO’s technical guidance defines a “person with laboratory confirmation of 2019-nCoV infection, irrespective of clinical signs and symptoms”.

The disease caused by the 2003 coronavirus was named SARS, for ‘severe acute respiratory syndrome‘. The other coronavirus that occasionally infects people causes an illness called MERS, for ‘Middle East respiratory syndrome‘.

Continue Reading
Comments

COVID19

Govt Warns Against Use Of N-95 Masks With Valved Respirators

There is “inappropriate use” of N-95 masks by the public other than designated health workers.

Published

on

NEW DELHI: The Centre has written to all states and union territories warning against the use of N-95 masks with valved respirators by people, saying these do not prevent the virus from spreading out and are “detrimental” to the measures adopted for its containment.

The Director-General of Health Services (DGHS) in the Ministry of Health, in a letter to the Principal Secretaries of health and medical education of states, said it has been observed that there is “inappropriate use” of N-95 masks, particularly those with valved respirators, by the public other than designated health workers.

“…I would like to draw your attention to the advisory on the use of home-made protective cover for face and mouth available on the website of the MoHFW,” read the statement by the DGHS.


The official referred to the advisory on the use of homemade protective cover for face and mouth available on the website of the Ministry of Health.

This advisory had been issued by the central government in April, asking people to use a homemade protective cover for face and mouth, particularly when they step outside of their residences.

The advisory stressed such face covers must be washed and cleaned each day, as instructed, and stated that any used cotton cloth can be used to make this face cover.


The colour of the fabric does not matter but one must ensure that the fabric is washed well in boiling water for five minutes and dried well before making the face cover.

It is to bring to your knowledge that the use of valved respirator N-95 masks is detrimental to the measures adopted for preventing the spread of coronavirus as it does not prevent the virus from escaping out of the mask. In view of the above, I request you to instruct all concerned to follow the use of face/mouth cover and prevent inappropriate use of N-95 masks,” DGHS Rajiv Garg said in the letter.

Continue Reading

COVID19

COVID-19: 7 Lakh People Have Now Recovered From Coronavirus In India

The fatality rate continues to decline and has come down to 2.43 per cent.

Published

on

NEW DELHI: The government today said a total of 7,24,578 people infected with Covid-19 have recovered in the country so far and the recovery rate is 62.72 per cent in India. And the case fatality rate continues to decline in the country and has come down to 2.43 per cent.

The Health and Family Welfare Ministry said, in a significant development a record number of 24,491 people have recovered in the past 24 hours.

Presently, the total number of active corona cases in the country is 4,02,529.


The Health Ministry said that a total of 37,148 new cases of Covid-19 have been reported in the country in the last 24 hours taking the total number of cases to 11,55,191.

In a single day, 587 deaths have been reported taking the nationwide toll to 28,084.

In terms of the recovery rate of coronavirus cases, Delhi is at the top with 84.78 per cent followed by Ladakh, Haryana, Telangana and Andaman and Nicobar Islands. In these five states and Union Territories, the recovery rate is above 73 per cent.


19 States and Union Territories have better recovery rates than the national average of 62.72 per cent.

In terms of the number of people recovered from Covid-19, Maharashtra leads the tally followed by Tamil Nadu, Delhi and Gujarat.

There are 29 States and Union Territories which have a lower fatality rate than the national average of  2.43 per cent.

In the total active cases, around 68 per cent caseloads are from Maharashtra, Tamil Nadu, Karnataka, Andhra Pradesh and Uttar Pradesh.

Meanwhile, Indian Council of Medical Research, ICMR reported that a total of 3,33,395 tests were conducted by various laboratories in the last 24 hours.


So far, 1,43,81,303 tests have been conducted in the country.

ICMR is continuously ramping up testing facilities and at present, a total of one thousand 274 laboratories across India are conducting Covid-19  tests. Of which,892 are government laboratories and 382 are private laboratory chains.

Continue Reading

COVID19

COVID-19: Inadequate Evidence To Suggest Nation-Level Community Transmission – AIIMS Delhi Director

Does not rule out the possibility of local level transmission in hotspots witnessing a huge spike in the number of cases.

Published

on

NEW DELHI: India is on fast track mode to develop a COVID-19 vaccine. Speaking to the media in New Delhi today, AIIMS Delhi Director Randeep Guleria informed that the Human trials for the indigenously developed COVAXIN have begun at the premier medical Institute.

He informed that after the registration procedure and blood sample tests of the health volunteers, the vaccine will be administered to 100 healthy individuals in the first phase.

Dr Guleria said that in the second phase 750 people will be recruited between 12 to 65 years of age for the human trials.


He said that the medical institute has received an overwhelming response in terms of volunteer registration for the trials.

Terming development of an indigenous vaccine as a great achievement, he informed that India’s mass production capacity of drugs and vaccines will also help in meeting the demands during its production stage.

Replying to a question on Community Transmission, Dr Guleria said, there is not much evidence that community transmission is happening at National level.


He, however, did not rule out the possibility of local level transmission in hotspots witnessing a huge spike in the number of cases.

Dr Guleria asserted that certain areas in the country, including the National Capital, appeared to have reached their peak and are now showing a significant decline in the number of cases.

He emphasized on continued aggressive action towards containment of infection in hotspots.

The AIIMS Director stressed on the need for the enhanced door to door testing and isolation measures.

Dr Guleria said that the measures adopted by the government for testing, tracing and treating COVID-19 patients have helped contain the fatality rates in the country as one of the lowest in the world.


Continue Reading

Most Read This Month

error: Content on this news portal is protected!